Ethanol enhances erbB-mediated migration of human breast cancer cells in culture

Breast Cancer Research and Treatment

Volumn 63, Issue 1, 2000, Pages 61-69

  Luo, Jia ^a   Miller, Michael W ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alcohol; Anti sense oligonucleotide; Epidermal growth factor; Growth factor receptors; Heregulin; Metastasis; Signal transduction

Indexed keywords

ALCOHOL; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR; RECEPTOR; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER RISK; CELL MIGRATION; CONCENTRATION RESPONSE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; FEMALE; GENES, ERBB; HUMANS; NEOPLASM METASTASIS; OLIGONUCLEOTIDES, ANTISENSE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0033783618     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006436315284     Document Type: Article

References (61)

1. Cancer morbidity in alcohol abusers
2. Alcohol and breast cancer in women - A pooled analysis of cohort studies
3. Alcohol consumption and breast cancer
4. Breast cancer: Magnitude of the problem and descriptive epidemiology
5. Alcohol beverage consumption in relation to risk of breast cancer: Meta-analysis and review
6. Alcohol and breast cancer: A review
7. Alcohol consumption and risk of breast cancer: A review of the epidemiologic evidence
8. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patient: Interview study from Third National Cancer Survey
9. Breast cancer risk and alcohol consumption: Results from a large case-control study
10. Alcohol consumption and breast cancer risk among women under age 45 years
11. Alcohol consumption and breast cancer stage at diagnosis
12. Epidemiology of in situ and invasive breast cancer in women aged under 45
13. Receptor blockade with monoclonal antibodies as anti-cancer therapy
14. Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma
15. Breast cancer
16. Amplification and overexpression of erbB-2 gene in human tumors: Its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy
17. The biology of erbB-2/neu/HER-2 and its role in cancer
18. Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance
19. The type 1 (EGFR-related) family of growth factor receptors and their ligands
20. Type I growth factor receptors: Current status and future work
21. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer
22. The neu (c-erbB-2) oncogene
23. HER-2/neu signal transduction in human breast and ovarian cancer
24. Studies of HER-2/neu protooncogene in human breast and ovarian cancer
25. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
26. The significance of heregulin in breast cancer tumor progression and drug resistance
27. Heregulin and agonsitic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that over express p185(c-erbB2); increased invasiveness may contribute to poor prognosis
28. Growth factor-mediated neural proliferation: Target of ethanol toxicity
29. Closed chamber system for delivery of ethanol to cell cultures
30. Ethanol inhibits bFGF-mediated proliferation of C6 glioma cells
31. Effects of ethanol on the expression of c-erbB proteins and heregulin-mediated MAP kinase activity in human breast cancer cells
32. Alcohol reduces the number of pheochromocytoma (PC 12) cells in culture
33. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
34. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
35. Differential sensitivity of human neuroblastoma cells lines to ethanol: Correlation with their proliferative responses to growth factors and expression of growth factor receptors
36. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
37. The erbB3 gene product is a receptor for heregulin
38. Developmental expression of c-neu proteins in cerebral cortex: Relationship to epidermal growth factor receptor
39. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness
40. Cell-type specific interaction of neu differentiation factor (NDF/heregulin) with neu/HER-2 suggests complex ligand-receptor relationships
41. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin
42. ErbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification
43. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants
44. Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment
45. Establishment and characterization of a cell line of human breast carcinoma origin
46. Differentially expressed genes associated with the metastatic phenotype in breast cancer
47. CAS/Crk coupling serves as a 'molecular switch' for induction of cell migration
48. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines
49. Arrest of epidermal growth factor-dependent growth in fetal hepatocytes after ethanol exposure
50. Ethanol-induced structural and functional alteration of epidermal growth factor receptor in buccal mucosa
51. Neuregulins and their receptors: A versatile signal module in organogenesis and oncogenesis
52. Induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
53. Heregulin induces tyrosine phosphorylation of HER4/p180(erbB4)
54. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2
55. Cooperative signaling of erbB3 and erbB2 in neoplastic transformation and human mammary carcinomas
56. The erbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
57. A neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth signaling
58. Isolation of the neu/HER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells
59. Identification of heregulin, a specific activator of p185(erbB2)